SHANGHAI and SAN DIEGO, July 9, 2020 — WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series “Collaborations That Transform,” highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary webinar, to be broadcast worldwide on July 16, will convene leading physicians, drug developers, patients and advocates. These experts will discuss the latest advances in the development of transformative medicines for hemophilia, including gene therapy and next generation technologies.
As an enabler of the biotech and medical device industry, WuXi AppTec shares the conviction that we must work collaboratively to solve industry-wide problems and bring transformational medicines to people living with rare diseases. On July 16, the webinar will continue the dynamic discussions that began with WuXi AppTec’s inaugural rare disease webinar in May. It is complimentary and open to the public.
WuXi AppTec welcomes all to join the conversation.
10:35 – 11:00 Addressing the Unknowns in an Era of Transformations
A conversation with Glenn Pierce, VP Medical, World Federation of Hemophilia, Entrepreneur-in-Residence at Third Rock Ventures, and Chief Medical Officer at Ambys Medicines; moderated by Hui Cai, VP and Head of Content Division, WuXi AppTec
11:00 – 12:00 The Quest for Transformative Medicines
John Pasi, Professor of Haemostasis and Thrombosis, Barts and the London School of Medicine and Dentistry, Queen Mary University of London
Richard Pezzillo, Executive Director, New England Hemophilia Association
Glenn Pierce, VP Medical, World Federation of Hemophilia
Rogerio Vivaldi, President & Chief Executive Officer, Sigilon Therapeutics
Guy Young, Director, Hemostasis and Thrombosis, Children’s Hospital Los Angeles; Professor of Pediatrics, University of Southern California Keck School of Medicine
Moderated by Richard Soll, Head of WuXi AppTec’s Boston office; Senior Advisor of Strategic Initiatives
Paige leveraged the world’s largest dataset in pathology to develop an unparalleled computation pathology offering
SANTA CLARA, California, July 8, 2020 — Based on its recent analysis of the North American AI-based digital pathology market, Frost & Sullivan recognizes Paige with the 2020 North American Enabling Technology Leadership Award for its disruptive product offering.
Paige
Paige has developed robust machine learning models for computational pathology for detecting cancer subtypes, thereby enhancing the diagnosis capability of pathologists worldwide. Paige’s AI-based technology was developed and tested on over 100,000 de-identified, digitized slide images from more than 16,000 cancer patients. The deep learning algorithms detected prostate cancer, skin cancer, and breast cancer with near-perfect accuracy.
“Paige’s AI algorithms validated against the world’s largest dataset in pathology makes it the most trustworthy best in class pathology diagnosis solution,” said Debarati Sengupta, Industry Analyst, Frost & Sullivan. “Paige’s technology eliminates the need to curate datasets, which is time-consuming and expensive. Paige’s AI based pathology offering enables pathologists to make a fast and accurate diagnosis of even the most complex and difficult to interpret slides.”
The Paige offering consists of general and organ-specific products that provide rapid diagnostic stratification, cancer detection, tumor segmentation, and prediction of treatment response, and overall survival. Its algorithms form a portfolio of AI-based digital diagnostics and biomarkers to help pathologists provide diagnoses. For security purposes, all datasets used to build the products were de-identified, and any protected health information or label text was removed.
Notably, Paige’s computational pathology offering received the Breakthrough Device designation by the US Food and Drug Administration (FDA) in 2019, making it the first such device for cancer diagnosis. Furthermore, it began commercializing in 2019 following its CE mark approval for Paige Prostate, which is a first-to-market prostate cancer detection solution, and a digital pathology viewer for the primary diagnosis of any digital slide. Paige’s AI-based solutions are vendor agnostic, which helps it serve a wider pool of customers.
In 2020, it formed a strategic partnership with Invicro LLC, a Konica Minolta company to provide its AI-based integrated pathology solutions to support Invicro’s drug discovery and development initiatives. “Paige continues to expand its footprint not just in commercial laboratories, but also in biopharmaceutical companies, positioning itself as a pioneer in AI-based digital pathology market” noted Sengupta.
Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products but also enables the development of new products and applications. The award recognizes the high market acceptance potential of the recipient’s technology.
Frost & Sullivan Best Practices awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.
About Frost & Sullivan For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
About Paige Paige was founded in 2017 by Thomas Fuchs, Dr.Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The Company builds computational pathology products designed so patients and their care teams can make faster, more informed treatment decisions. With this new class of diagnostic devices positioned to drive the future of pathology, Paige created a platform to deliver this novel technology to pathologists to transform their workflow and increase diagnostic confidence and productivity. Paige’s lightweight platform was purpose-built with pathologists to offer an intuitive user experience, minimize IT burden and costs while ensuring patient safety and data privacy. Our products deliver insights to pathologists so they can arrive efficiently at more precise diagnoses for patients. Paige is the first and only company to receive FDA breakthrough designation for computational pathology products.
Two new AI features for in-store analytics made possible by Xovis 3D sensors
ZOLLIKOFEN, Switzerland, July 2, 2020 — When their ordinary "all-in-a-day’s-work" became extraordinary, Xovis ramped up their R&D to solve unforeseen challenges. Today, the company proudly presents two new AI features for their 3D people counting sensors: Face Mask Detection and View Direction. While View Direction had been hinted at in January this year, Face Mask Detection has sprung up out of the current situation with COVID-19. Xovis hopes that this will help their customers stay on top of public health regulations. The company’s innovative and GDPR compliant technology becomes the only kind to detect face masks directly on 3D sensors.
The Xovis Face Mask Detection
The Xovis View Direction
As Xovis Head of Retail Anne Wyder explains, "COVID-19 has made face masks compulsory in many public places; we have responded by developing a new AI feature for our sensors to recognize whether or not face masks are in fact being worn. In a bid to help businesses adhere to public health regulations, this new software plugin for Face Mask Detection will be free of charge until the end of the year for our integrator partners working with the Xovis Cloud Account."
Despite COVID-19, and at the same time because of the global crisis that has ensued, Xovis is actively providing technological solutions for both occupancy and physical distancing management. As Xovis CPO Christian Studer puts it: "We have been busy – we’ve not only finished development of the much-anticipated View Direction plugin for in-store analytics, but in an agile response to changing market demands also stepped up to the plate and created something extra in our firmware for our customers. Both Face Mask Detection and View Direction features provide deeper insight into customer behavior – the analysis of which has become more important than ever before."
As the undisputed innovator of people flow technology based on 3D stereovision sensors, Xovis is committed to bringing the best products and services to customers and partners alike. Because people count.
SHENYANG, China, July 2, 2020 — Recently, International Data Corporation (IDC) has released the China Market Shares of Core Hospital Management Systems 2019: Upgrading Core Systems to Support Healthcare Digital Transformation. According to this report, Neusoft took the first place in China core hospital management systems solutions market in 2019 and topped the ranking of China healthcare IT solutions market for the tenth consecutive year, continuing leading the healthcare informatization construction in China.
In the healthcare informatization sector, Neusoft is a leading provider of intelligent healthcare integrated solutions in China. With the largest client base in the industry in China as well as the best practices in various sub-sectors, Neusoft is striving to facilitate the rapid development of healthcare informatization and promoting China’s healthcare system reform. Neusoft is also the first large provider to have launched core hospital management systems, with leading market shares as well as advanced concepts and products.
With over two decades’ devotion to the healthcare sector, Neusoft consistently commits itself to utilizing information technologies to promote the harmonious development of the healthcare ecosystem. Nowadays, Neusoft’s healthcare business has covered hospital informatization, health insurances, medical equipment, cloud hospitals, medical big data and intelligence, health and medical education, medical IoT and 5G, etc., and Neusoft has built a sustainable IT-centric ecosystem.
In the future, Neusoft will continue to empower the healthcare industry through software. Neusoft will keep promoting the integration of information technology and the healthcare, make the new technologies like artificial intelligence, blockchain, cloud computing, big data, internet of things become new medical elements, and build a sustainable healthcare ecosystem for creating more value for the society, industry and clients.
Businesses and workers call for greater flexibility, questions raised over the hours-based contract, and a new empathetic leadership profile emerges
ZURICH, June 30, 2020 —
Workers demand greater flexibility after coronavirus, with a 50/50 split of remote and office time confirmed as the universal ideal
Questions raised over the hours-based contract, with 69% saying contracts should be based on results delivered rather than hours worked
Boom in digital skills an unintended consequence of lockdown, with tech knowhow improving for six in 10 (61%), and two thirds (69%) eager for further digital upskilling post-pandemic
Leaders need to reinvent themselves as more emotionally intelligent, but they are not prepared, as less than half felt equipped to support employees holistically during the pandemic
The coronavirus pandemic has resulted in pivotal shifts in attitudes and expectations among workers and leaders, as both call for permanent changes in how and where we work, workplace relationships and future skills, according to new research from the Adecco Group.
The Adecco Group, the world’s leading HR solutions company, today unveiled the results of its latest study, Resetting Normal: Defining the New Era of Work, examining the expected short- and long-term impact of the pandemic on resetting workplace norms. Fieldwork was conducted in May 2020, with 8,000 office-based respondents (aged 18-60) across Australia, France, Germany, Italy, Japan, Spain, the UK and the USA.
The Adecco Group’s Chief Executive Officer, Alain Dehaze, said: “The world of work will never return to the ‘normal’ we knew before the pandemic struck. The sudden and dramatic change in the workplace landscape has accelerated emerging trends such as flexible working, high-EQ leadership, and re-skilling, to the point where they are now fundamental to organisational success. As many countries emerge from the acute crisis phase of the pandemic, employers have an opportunity to ‘hit reset’ on traditional workplace practices – many of which have remained largely unchanged since the industrial revolution. This research highlights that employee attitudes have shifted and gaps between workforce expectations and entrenched labour market processes have been exposed. As we step into the new era of work, now is the time to establish better norms that will enable a holistically healthy, productive and inclusive workforce into the future.”
Key research highlights:
The research revealed that the working world is ready for a new “hybrid” model, with three quarters (74%) of workers surveyed saying a mix of office-based and remote working is the best way forward. The universal ideal of spending half (51%) of their time in the office and half working remotely (49%) transcends geographies, generations and parental status. And company executives agree, with almost eight in ten (77%) C-suite leaders saying businesses will benefit from increased flexibility.
Another stark finding could signal the end of the hours-based contract and 40-hour week. More than two thirds (69%) of workers are in favour of “results-driven work,” whereby contracts are based on delivering against business needs rather than working a set number of hours. A high proportion of C-suite executives (74%) agree that the length of the working week should be revisited.
The pandemic has also demanded a new set of leadership competencies and these expectations are expected to accelerate a reinvention of the modern-day leader. Emotional intelligence has clearly emerged as the defining trait of today’s successful manager, but the soft skills gap is evident. Over a quarter (28%) of those questioned said their mental wellbeing had worsened due to the pandemic, with only 1 in 10 rating their managers highly on their ability to support their emotional health.
In a similar nature to flexible working, the findings demonstrate a universal appetite for mass upskilling. Six in 10 say their digital skills have improved during lockdown, while a further two thirds (69%) are looking for further digital upskilling in the post-pandemic era. A broad range of skills development were identified as important by the workforce, including managing staff remotely (65%), soft skills (63%) and creative thinking (55%).
Finally, the findings highlighted the importance of sustaining trust in the new working world. Companies have risen to the challenge of supporting their people during the crisis, and as a result, trust in corporations has increased. In fact, 88% say that their employer met or exceeded their expectations in adapting to the challenges of the pandemic. And with this increased trust comes increased expectations. While the future of work is a collective responsibility, 80% of employees believe their employer is responsible for ensuring a better working world post-COVID and resetting norms, compared with 73% who say the government is responsible, 72% who agree it is an individual responsibility, and 63% who believe it is in the hands of labour unions.
For more information:
Download the Resetting Normal: Defining the New Era of Work full report here.
Follow us on social #ResetNormal for updates
About the Adecco Group
The Adecco Group is the world’s leading HR solutions company. We believe in making the future work for everyone, and every day enable more than 3.5 million careers. We skill, develop, and hire talent in 60 countries, enabling organisations to embrace the future of work. As a Fortune Global 500 company, we lead by example, creating shared value that fuels economies and builds better societies. Our culture of inclusivity, entrepreneurship and teamwork empowers our 35,000 employees and we are proud to have been consistently ranked one of the ‘World’s Best Workplaces’ by Great Place to Work®. The Adecco Group AG is headquartered in Zurich, Switzerland (ISIN: CH0012138605) and listed on the SIX Swiss Exchange (ADEN) and powered by nine global brands: Adecco, Adia, Badenoch & Clark, General Assembly, Lee Hecht Harrison, Modis, Pontoon, Spring Professional and Vettery.
SHANGHAI, June 27, 2020 — With the COVID-19 pandemic threatening individuals and businesses worldwide, infection risk management has been a tough challenge. To help companies better handle this problem, DNV GL, one of the world’s largest assurance companies with over 15,000 professionals globally and over 110,000 customers, has designed, developed and released a blockchain-enabled infection risk management solution called My Care, which aims to assess, manage and mitigate infection risk in management processes, business dealings and operations for enterprise users.
This new initiative and product by DNV GL will be enhanced and powered by VeChain’s blockchain technology. In particular, the VeChain ToolChainTM BaaS Platform will be used to support DNV GL to launch this brand-new digital product in a rapid lead time.
First enterprise level customer to take advantage of this new solution is Viking Line, a publicly traded shipping company with an annual revenue of ~EUR 500 million. On June 17th, 2020, the company Viking Line announced to use My Care. More companies are expected to be on-board as DNV GL expands the scope of the product and enterprise adoption efforts.
VeChain Enhances DNV GL’s Digital Transformation Strategy
Since the announcement of our strategic partnership in January 2018, the collaboration between VeChain and DNV GL has been progressively promoting the adoption of blockchain to help enterprises bolster the transparency and trust between their customers and products. VeChain has been the infrastructural technology behind the various blockchain powered initiatives offered by the DNV GL portfolio of services.
By using VeChain ToolChainTM, DNV GL took the first step in May 2019 to develop its My StoryTM, a digital assurance solution that aims to track each stage of a product’s manufacturing cycle with the use of blockchain technology. My StoryTM is just one of the many different VeChain-powered services that DNV GL offers.
My CareTo Assist COVID-19 Infection Risk Management
As the world grapples with COVID-19, managing infection risk requires a new approach to disease control and prevention, and new operating procedures and assurance practices would need to be introduced. This led to the introduction of My Care to assist companies on preparedness and readiness of infection risk management.
With the combination of standard templates, customizable tools, data value visualization tools and third-party certification services, VeChain ToolChainTM has been the technical foundation for different digital solutions. DNV GL’s My Care is another one of them that will utilize the VeChainThor blockchain for all data related purposes.
A Hospital-Grade Solution To Resolve COVID-19 Pain Points In Enterprises
The My Care methodology is derived from the approach DNV GL applies to assess infection risk management in hospitals. The solution is a suite of independent assessment services designed to help businesses reassure stakeholders that they have put infection risk management at the core of their risk management strategy. It brings together aspects of DNV GL’s healthcare standards, best practices in risk management, HSE (health, safety, and environment) and quality management systems and maturity safety rating standards.
For customers and other stakeholders, scanning the QR-code embedded in the My Care trust mark will provide users access to DNV GL’s assessment statement. These assessment statements are stored on VeChainThor blockchain, providing added trust and integrity. With blockchain, businesses can be assured that their infection risk management and best practices is effectively communicated to customers.
For enterprises looking to return to business, My Care’s holistic approach affirms its capability to manage and prevent infection risks, including COVID-19, enables readiness to deal with infectious diseases today and can drive lasting changes that build long-term business resilience.
Blockchain Powered Solutions To Further Expand On A Global Scale
As a major emerging technology in various industries, blockchain is quickly bringing about further digitization in the business world, which is an opportunity for both VeChain and DNV GL to further enhance our strategic partnership and facilitate business growth.
VeChain ToolChainTM has been receiving acknowledgement from various industries as a solution for persistent problems that hold back business growth, such as sustainability management, supply chain optimization, responsible manufacturing, and real-time asset flows.
Sunny Lu, co-founder and CEO at VeChain stressed, “As we contend with the new normal due to COVID-19, the demand for trust has never been so important. Blockchain will be one of the driving forces to increase confidence in data integrity, business credibility, and mutual trust in multi-party collaboration. With VeChain ToolChainTM, we have great confidence to support DNV GL’s digital transformation strategy to develop more digital solutions like My StoryTM and My Care to expand and improve their offerings to serve their clients worldwide.”
About VeChain
Launched in 2015, VeChain connects blockchain technology to the real world by providing a comprehensive governance structure, a robust economic model, and IoT integration. VeChain is the pioneer of real-world applications using public blockchain technology, with international operations in Singapore, Luxembourg, Tokyo, Shanghai, Paris, Hong Kong, and San Francisco. Together with our strategic partners PwC and DNV GL, we have established cooperative relations with many leading enterprises in different industries, including Walmart China, BMW, BYD Auto, Haier, H&M, LVMH, D.I.G, ENN, Shanghai Gas, AWS, PICC, ASI etc.
Nationwide deployed QR code tracing system would be effective in case of second surge of COVID-19
SEOUL, South Korea, June 25, 2020 — A cybersecurity startup and a member company of the Born2Global Centre, swlDch suggests dynamic, unidirectional QR code technology that can encourage wider user adoption as well as protect user privacy.
Strict measures are eased as the number of COVID-19 cases is falling. However, concerns remain that further surges of cases may be on the horizon. Even countries with effective strategies have seen second wave spikes and clusters of cases. So when the World Health Organization says the virus may be here to stay, nations need to understand that they will experience new cases. The challenge is how to predict, track and handle them. It is crucial to keep test and trace momentum to manage the epidemic in a timely manner. Under this circumstance, many governments try to adopt contact-tracing app on a national scale. In the UK, a new NHS contact-tracing app will be in place. The app allows smartphones to track every other device they have come into contact with, exchanging anonymous IDs using Bluetooth signal. Once the case is confirmed, it then informs other users in close contact through the app.
South Koreais taking a slightly different approach. They focus on tracking visitors at high-risk facilities by adopting a QR Code based electronic registration system. This became compulsory because South Korean authorities have experienced considerable difficulties in their epidemiological investigation of the night club outbreak in May. Much of the information on handwritten visitor logs was found to be false or incomplete. From 10 June, visitors to those indoor venues such as nightclubs, Karaoke clubs, and gyms will be required to use an app that generates a one-time personalized QR code that can be scanned at the door. Utilizing QR code technology is basically a tokenization that helps to collect visitors’ information and recall the information in case of an emergency.
However, this tokenization technology is likely to encounter a problem of limited coverage that is disrupting the national roll-out. Since it requires an active network connection for generating tokens, visitors who use entertainment venues located in the basement often experience serious latency during the code generation process. In addition, the more device connected to a network, the larger its attack surface grows, making easier for hackers to infiltrate the network. This can bring serious consequences like a breach of personal data. Some may question why individuals should bear the cost of mobile data for a service they are reluctant to use. On the other hand, the current system also causes technical challenges to QR code providers. They are required to be equipped with a great level of server capacity and computing resources in order to handle massive overhead from storing to encrypting/decrypting the tokens and information.
How current QR code tracing works? How OTAC QR code tracing works?
swIDch‘s OTAC (One Time Authentication Code) technology can be an alternative solution, tackling the network connection issue of the QR code tracking system. This patented algorithm of OTAC enables to generate dynamic QR code on visitors’ smartphone even in off-the-network environment. Since OTAC does not require an active network connection, it can secure visitors information from hacking. In addition, it removes friction from user journeys by reducing heavy network traffic for generating tokens and server loads for persisting token details. In other words, system operators can save significant resources for processing tokens. As a result, the government can operate the system with larger coverage with less technical challenges.
The nationwide rollout is the key to efficiently operate the tracking system. Even though it is compulsory by the government, frictionless use of the system should be supported to encourage citizen’s participation. swIDch believes that OTAC can increase adoption and use of the QR code tracking system by providing uninterrupted, safe, and easy use of the system. The company actively proposes the solution to other states typically in developing countries where a network connection is unstable. Inspired by UN’s Sustainable Development Goals (SDGs), the company is willing to distribute its technology for free to any other country upon its requirement to tackle the global COVID-19 crisis together.
swIDch Ltd. (www.swidch.com) is a cybersecurity start-up based in London with R&D center in South Korea. The company helps businesses to identify and authenticate its users through our patented algorithm, one-time authentication code that generates in a networkless environment, to tackle problems of identity theft and CNP frauds. It is a security feature for uninterrupted use of devices by combining user identification and authentication steps into one only with the dynamic authentication code. Since its foundation in 2018, the company has chosen for the leading accelerator programmes in Europe and Asia – LORCA, Global Entrepreneur Programme, and Accenture FinTech Innovation Lab. Furthermore, swIDch gained global recognition for its innovative authentication technology, selected for XTC (Extreme Tech Challenge) finalist, winner of the hottest Cybertech Company from Europas 2020, and the annual list of the world’s most innovative Cybertech Company ‘Cybertech100’.
About Born2Global Centre
Born2Global Centre (www.born2global.com) is a full-cycle service platform for global expansion. Since inception in 2013, Born2Global has been setting the standard for successful startup ecosystem as the main Korean government agency under the Ministry of Science and ICT. Born2Global has expanded and transformed startups to be engaged, equipped and be connected with the global market.
SINGAPORE, June 25, 2020 — Singapore-based biotech company TurtleTree Labs today announced the completion of a fresh round of funding from global investors. TurtleTree Labs is the world’s first-cell based biotechnology company creating real milk from mammalian cells, without the need for animals. As a platform, the company’s focus is on high value human breast milk followed by cow milk.
TurtleTree Labs Founders Max Rye and Fengru Lin
Over the past year TurtleTree Labs has attracted world class talent, currently boasting a team of more than 20 full-time scientists and engineers. With multiple cross-functional teams working in parallel, co-founder and CEO Fengru Lin says, “Our team is hungry, passionate and knows what it takes to accelerate to market. I’m so inspired when even the most junior scientists are sharing ideas of cutting costs or identifying better suppliers.”
With support from the Singaporean government, the startup has been privy to an array of resources that provided TurtleTree Labs with a tremendous financial boost, enabling it to continue working during the COVID-19 pandemic. Co-founder Max Rye, originally from the San Francisco Bay area explains, “Our teams are firing on all cylinders thanks to Enterprise Singapore and the support from our investors. We remain as focused as ever, and we aim to continue hitting milestones.”
“TurtleTree Labs’ goal of creating milk from animal cells provides a novel solution towards sustainable dairy production globally, and would also help to strengthen Singapore’s long-term food diversification efforts. We are encouraged that Singapore’s foodtech infrastructure has enabled homegrown startups like TurtleTree Labs to push technological boundaries and obtain quick access to capital. We will continue our efforts to develop a vibrant agri-food tech ecosystem in Singapore to encourage the creation of more innovative solutions,” said Ms Bernice Tay, Director, Food Manufacturing Division, Enterprise Singapore.
Investors taking part in the TurtleTree Labs seed round are Green Monday Ventures, KBW Ventures, CPT Capital, Artesian, and New Luna Ventures.
“Food tech innovation in Asia is way overdue. If the rapidly deteriorating climate change situation isn’t enough to convince the world, the pandemic surely hammers home the urgency that we need to overhaul the food system for the sake of public health, food safety, and food security. That explains why Green Monday Ventures is so excited to invest in and collaborate with TurtleTree Labs. We see immense possibilities in their biotech innovation platform, as well as enormous impact we can drive together,” says David Yeung, founder, Green Monday Group
“KBW Ventures has invested in the seed round building on our initial commitment during TurtleTree’s pre-seed raise. We see the founding team commitment and the potential of this company and its technology as a winning combination. Now more than ever, people are waking up to the benefits of food technology and the massive positive implications of innovations in cellular agriculture,” said Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures.
TurtleTree Labs raised its initial investment which was led by New York–Hong Kong based Lever VC in 2019, with investors from various geographies. “This fresh round of funding will enhance our scale up development, bringing us one step closer to commercialization,” said Max Rye.
TurtleTree Labs – TurtleTree Labs is the first biotech company in the world with the ability to create milk from all mammals. Using their proprietary cell-based methods, they will shape the future of not just how we get dairy milk but how humans will feed their infants. To maximise impact, the team will work with industry leaders to adopt their sustainable and safe methods to create milk. Their focus on impact will disrupt this multi-billion dollar industry while reducing the carbon footprint on this planet, while creating milk free of contaminants. Their innovation will provide millions access to safer, reliable and higher quality dairy products.
Green Monday Ventures – Green Monday Group has an overall mission to “Make Change Happen, Make Green Common” since its establishment in 2012. It is achieved by promoting plant-based eating and environmental protection through its multifaceted social venture model, in hopes of tackling climate change, global food in security and promoting public health. Green Monday Foundation, Green Monday Holdings and Green Monday Ventures are the three main branches of Green Monday Group. Green Monday Ventures is the impact investment arm aimed at accelerating the growth of mission-aligned entrepreneurs and startups globally.
KBW Ventures – KBW Ventures, founded by Chief Executive Officer HRH Prince Khaled bin Alwaleed bin Talal Al Saud, invests in companies with transformative technologies and business models and the potential for significant financial returns while also delivering positive social impact. The KBW Ventures portfolio spans the venture capital spectrum from earlier stage ventures, to more established companies looking to expand into the Middle East.
CPT Capital – CPT Capital is the venture arm of a leading private family office. As a long-standing dedicated investor in the alternative protein space, CPT Capital has unmatched experience and expertise investing in companies disrupting the food system.
Artesian – Artesian is a full-stack VC firm investing from seed stage through to exit. The Artesian portfolio comprises over 400 investments across Australia, China, South East Asia, South Asia and the Americas.
New Luna Ventures – New Luna Ventures is a leading impact venture capital advisor and investor in the food 2.0, agriculture, energy, community enrichment, and enabling software industries. We help entrepreneurs build sustainable ventures and connect disruptive ideas with investors and partners. Together, we provide actionable plans, enhanced communications, and expanded access to markets.
South Korea Center for Disease Control is revolutionizing their contact tracing program with innovative cloud contact center technology to contain the spread of COVID-19
SOUTH SAN FRANCISCO, California, June 18, 2020 — Bright Pattern, a leading provider of AI-poweredcloud contact center software for innovative companies, announced today that it was deployed by South Korea’s Center for Disease Control for citizen outreach and contact tracing during the COVID-19 pandemic. South Korea launched a massive, technology-reliant testing and tracing campaign to combat the spread of COVID-19. Their efforts have been meticulous and includes entry registration for nightclubs and gyms, health-monitoring phone apps, and a high-tech remote contact center powered by Bright Pattern, the No. 1 provider of omnichannel cloud contact center technology. Publications such as Forbes and the Guardian noted their leadership in containing the virus was a direct result of their contact center tracing using the Bright Pattern platform.
The Center for Disease Control selected Bright Pattern because of its innovative cloud-based software, speed of deployment, and ease of use requiring little to no product training for remote workforces. As reported by the national news in South Korea, the largest obstacle faced when deploying the remote agents was security issues, such as personal information leakage. By using Bright Pattern, a 100% cloud-based contact center platform, employees can connect directly to the cloud server from their home. Cloud contact center technology is being deployed in all of the 339 Center for Disease Control call centers.
Additionally, remote centers will protect contact center agents, allowing them to work from home. "[This remote model] is expected to set the customer center staff free from the periphery of the danger of infection," noted a Naver customer support leader on the Seoul Broadcasting System’s national news.
"The COVID-19 pandemic has affected lives and company’s around the world and the call center industry is no exception," said Michael McCloskey, CEO of Bright Pattern. "Bright Pattern’s solutions can be used remotely, where work from home agents can seamlessly supplement companies current workforce to provide a personalized and effortless experience to your customers virtually. We are proud to help the country leading the way in contact tracing efforts, taking massive strides to contain the virus."
If you are experiencing a spike in calls as a result of the outbreak or need to deploy a remote workforce, Bright Pattern is prepared to deliver consultations and cloud services to existing and new customers. Please contact us at marketing@brightpattern.com, call 925-548-0532, or request a demo.
About Bright Pattern Bright Pattern provides the simplest and most powerful AI-powered contact center for innovative midsize and enterprise companies. With the purpose of making customer service brighter, easier, and faster than ever before, Bright Pattern offers the only true omnichannel cloud platform with embedded AI that can be deployed quickly and nimbly by business users—without costly professional services. Bright Pattern allows companies to offer an effortless, personal, and seamless customer experience across channels like voice, text, chat, email, video, messengers, and bots. Bright Pattern also allows companies to measure and act on every interaction on every channel via embedded AI omnichannel quality management capability. The company was founded by a team of industry veterans who pioneered the leading contact center solutions and today are delivering architecture for the future with an advanced cloud-first approach. Bright Pattern’s cloud contact center solution is used globally in over 26 countries and 12 languages.
BARCELONA, Spain, June 18, 2020 /PRNewswire/ — In May 2020, Herta was awarded with the COVID-19 Seal of Excellence certificate delivered by the European Commission (EC) for the project AWARE.
Seal Of Excellence Herta
AWARE was sent for evaluation to the European Innovation Council (EIC) Accelerator Pilot. As stated by the EC, the EIC Accelerator Pilot offers Europe’s brightest and boldest entrepreneurs the chance to step forward and request funding for breakthrough ideas with the potential to create entirely new markets or revolutionize existing ones. Highly innovative SMEs with a clear commercial ambition and a potential for high growth and internationalization are the prime target. The 20th of March 2020, the EC made an urgent call through the EIC Accelerator Pilot for technologies and innovations that could help in treating, testing, monitoring or other aspects of the Coronavirus outbreak.
The COVID-19 Seal of Excellence is a highly competitive quality label awarded to project proposals which were evaluated to have a high excellence and impact to deserve funding in this special call, but did not receive it due to current EC’s budgetary constraints.
AWARE proposes a hybrid edge and distributed solution for advanced video analytics, including real-time face recognition and crowd behaviour analysis. Part of the computing pipeline is executed on-premise, on low-power and small-size edge stations using Deep Neural Network accelerator hardware. This allows saving costs and increasing system’s scalability, efficiency and ease-of-installation. HERTA’s cutting-edge algorithms, which are able to identify people even when wearing masks and monitor crowd density, are integrated in the solution. The automatic control of social distancing and the identification of persons in access controls without the need of removing masks become vitally important to control the spread of COVID-19, and are Herta’s main focus to fight against the pandemic.
